Related Experiment Video
Updated: Sep 5, 2025

Proteomics to Identify Proteins Interacting with P2X2 Ligand-Gated Cation Channels
Published on: May 18, 2009
The P2X1 receptor as a therapeutic target
Felix M Bennetts1, Jesse I Mobbs1, Sabatino Ventura1
1Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.
The P2X1 receptor, a target for male contraception and bladder dysfunction, shows promise for treating thrombosis and inflammation. New small molecule antagonists require further validation for drug development.
Area of Science:
- Pharmacology
- Molecular Biology
- Drug Discovery
Background:
- The P2X1 receptor is a purinergic ligand-gated ion channel involved in various physiological processes.
- It plays a critical role in smooth muscle contraction, immune cell function, and cardiovascular regulation.
Purpose of the Study:
- To explore the P2X1 receptor as a drug target for male contraception, bladder dysfunction, thrombosis, and inflammatory conditions.
- To review the current status of P2X1 receptor antagonist development and future prospects.
Main Methods:
- Literature review of P2X1 receptor function and drug development efforts.
- Analysis of the potential therapeutic applications based on P2X1 receptor's physiological roles.
Main Results:
- P2X1 receptor antagonists are emerging as potential therapeutics.
- Further biological validation is needed for selectivity and drug-like properties of current antagonists.
- Determining the atomic structure of P2X1 receptor is a key future goal.
Conclusions:
- The P2X1 receptor is a versatile drug target with potential applications in male contraception, urology, cardiovascular diseases, and inflammatory disorders.
- Advancements in structural biology may accelerate the development of effective P2X1 receptor-targeting drugs.
More Related Videos
11:47Real-time Live-cell Flow Cytometry to Investigate Calcium Influx, Pore Formation, and Phagocytosis by P2X7 Receptors in Adult Neural Progenitor Cells
Published on: April 3, 2019
07:13Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
Published on: May 24, 2024
Related Concept Videos
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Ligand-Gated Ion Channel Receptor: Gating Mechanism
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...